Page last updated: 2024-08-25

rosiglitazone and Neuroblastoma

rosiglitazone has been researched along with Neuroblastoma in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (58.33)29.6817
2010's5 (41.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, SJ; Cheng, YC; Chiang, MC; Huang, RN; Lin, KH; Nicol, CJ; Yen, CH1
Freudlsperger, C; Kaltschmidt, C; Kompisch, K; Lorke, DE; Lukacs, Z; Müller, R; Rudolph, T; Santer, R; Schulz, D; Schumacher, U; Ullrich, K1
Lin, TN; Wu, JS; Wu, KK1
Alvarado, CS; Christensen, JG; Crosswell, HE; Dasgupta, A; De, P; Durden, DL; Findley, HW; Watt, T1
Balzi, M; Benvenuti, S; Cellai, I; Ceni, E; Deledda, C; Faraoni, P; Galli, A; Gelmini, S; Luciani, P; Peri, A; Petrangolini, G; Pratesi, G; Ricordati, C; Serio, M; Tortoreto, M1
Krieger-Hinck, N; Müller, A; Schumacher, U; Valentiner, U1
Ahn, JH; Cheon, HG; Cho, HS; Kim, KY; Lee, SH1
Cheng, LY; Liu, W; Wang, L; Yu, CJ; Zhang, YN1
Camacho, IE; De Strooper, B; Dominguez, D; Merchiers, P; Serneels, L; Spittaels, K1
Ahn, CW; Cha, BS; Jung, TW; Kang, ES; Kim, SK; Lee, HC; Lee, JY; Shim, WS2
Baglioni, S; Benvenuti, S; Cellai, I; Ceni, E; Galli, A; Luciani, P; Muratori, M; Ottanelli, B; Peri, A; Serio, M; Simi, L; Thiele, CJ1

Other Studies

12 other study(ies) available for rosiglitazone and Neuroblastoma

ArticleYear
Rosiglitazone activation of PPARγ-dependent signaling is neuroprotective in mutant huntingtin expressing cells.
    Experimental cell research, 2015, Nov-01, Volume: 338, Issue:2

    Topics: Animals; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Disease Models, Animal; DNA-Binding Proteins; Endoplasmic Reticulum Stress; Heat Shock Transcription Factors; Heat-Shock Proteins; Huntingtin Protein; Huntington Disease; Mice; Mitochondria; Nerve Tissue Proteins; Neuroblastoma; Neuroprotective Agents; Nuclear Proteins; PPAR gamma; Proteasome Endopeptidase Complex; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transcription Factors; Ubiquitin; Up-Regulation

2015
High concentrations of phenylalanine stimulate peroxisome proliferator-activated receptor gamma: implications for the pathophysiology of phenylketonuria.
    Neurobiology of disease, 2008, Volume: 32, Issue:3

    Topics: Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation; Humans; Immunohistochemistry; Microarray Analysis; Neuroblastoma; Neurons; Phenylalanine; Phenylketonurias; PPAR gamma; Rosiglitazone; Thiazolidinediones

2008
Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.
    Journal of cellular physiology, 2009, Volume: 220, Issue:1

    Topics: 3-Phosphoinositide-Dependent Protein Kinases; Anilides; Animals; Apoptosis; bcl-Associated Death Protein; bcl-X Protein; Caspase 3; Caspase 9; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Cytochromes c; Cytoprotection; Dose-Response Relationship, Drug; Glucose; Hydrogen Peroxide; Membrane Potential, Mitochondrial; Mice; Mitochondria; Neuroblastoma; Phosphorylation; Poly(ADP-ribose) Polymerases; PPAR gamma; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Reperfusion Injury; RNA Interference; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones; Time Factors; Transfection; Up-Regulation

2009
PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte growth factor-stimulated migration and proliferation of c-Met-positive neuroblastoma cells.
    BMC cancer, 2009, Nov-25, Volume: 9

    Topics: Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Proliferation; Hepatocyte Growth Factor; Humans; Hypoglycemic Agents; Indoles; MAP Kinase Signaling System; Neoplasm Staging; Neuroblastoma; Proto-Oncogene Proteins c-met; PTEN Phosphohydrolase; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Sulfones; Thiazolidinediones; Transfection

2009
In vivo effects of rosiglitazone in a human neuroblastoma xenograft.
    British journal of cancer, 2010, Feb-16, Volume: 102, Issue:4

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 9; Mice; Mice, Nude; Neovascularization, Pathologic; Neuroblastoma; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tissue Inhibitor of Metalloproteinase-1; Tumor Burden; Xenograft Model Antitumor Assays

2010
The effect of the PPAR-gamma agonist rosiglitazone on neuroblastoma SK-N-SH cells in a metastatic xenograft mouse model.
    Oncology research, 2010, Volume: 18, Issue:8

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Female; Humans; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Neoplasm Metastasis; Neuroblastoma; PPAR gamma; Rosiglitazone; Thiazolidinediones; Xenograft Model Antitumor Assays

2010
Neuroprotective effects of KR-62980, a new PPARγ agonist, against chemical ischemia-reperfusion in SK-N-SH cells.
    Brain research, 2011, Feb-04, Volume: 1372

    Topics: Cell Death; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Humans; Indenes; Morpholines; Neuroblastoma; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase Type II; Organic Chemicals; Phosphorylation; PPAR gamma; Reactive Oxygen Species; Rosiglitazone; Signal Transduction; Sodium Azide; Thiazolidinediones; Time Factors

2011
Rosiglitazone protects neuroblastoma cells against advanced glycation end products-induced injury.
    Acta pharmacologica Sinica, 2011, Volume: 32, Issue:8

    Topics: Cell Line, Tumor; Cell Survival; Glycation End Products, Advanced; Humans; Neuroblastoma; Neurons; Neuroprotective Agents; Rosiglitazone; Thiazolidinediones

2011
Peroxisome-proliferator-activated receptor gamma induces a clearance mechanism for the amyloid-beta peptide.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004, Dec-01, Volume: 24, Issue:48

    Topics: Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Anilides; Animals; Aspartic Acid Endopeptidases; Cell Line; Cell Line, Tumor; Cells, Cultured; Cerebral Cortex; Chromans; Culture Media, Conditioned; Endopeptidases; Humans; Kidney; Mice; Neuroblastoma; Neuroglia; Neurons; Peptide Fragments; Pioglitazone; PPAR gamma; Protein Processing, Post-Translational; Receptor, Notch1; Receptors, Cell Surface; Recombinant Fusion Proteins; Retinoid X Receptors; Rosiglitazone; Thiazolidinediones; Transcription Factors; Tretinoin; Troglitazone

2004
Rosiglitazone protects human neuroblastoma SH-SY5Y cells against acetaldehyde-induced cytotoxicity.
    Biochemical and biophysical research communications, 2006, Feb-03, Volume: 340, Issue:1

    Topics: Acetaldehyde; Apoptosis; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Combinations; Humans; Neuroblastoma; Neuroprotective Agents; Rosiglitazone; Thiazolidinediones

2006
Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells.
    British journal of cancer, 2006, Oct-09, Volume: 95, Issue:7

    Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Brain Neoplasms; Caspase 3; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Immunohistochemistry; Matrix Metalloproteinase 9; Neuroblastoma; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tissue Inhibitor of Metalloproteinase-1; Transcriptional Activation; Transfection

2006
Rosiglitazone protects human neuroblastoma SH-SY5Y cells against MPP+ induced cytotoxicity via inhibition of mitochondrial dysfunction and ROS production.
    Journal of the neurological sciences, 2007, Feb-15, Volume: 253, Issue:1-2

    Topics: 1-Methyl-4-phenylpyridinium; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Cytochromes c; Herbicides; Humans; Hypoglycemic Agents; Mitochondria; Neuroblastoma; Neurons; Neuroprotective Agents; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; RNA, Messenger; Rosiglitazone; Thiazolidinediones

2007